Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Scott R, Solomon"'
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract This paper provides the methodologies of a new summary curve that measures the dynamic outcome following allogenic hematopoietic cell transplantation. This new summary curve computes the probabilities that a patient is alive in remission and
Externí odkaz:
https://doaj.org/article/5a18141479a1416a80168095319328f3
Autor:
Scott R. Solomon, Andrew St. Martin, Nirav N. Shah, Giancarlo Fatobene, Monzr M. Al Malki, Karen K. Ballen, Asad Bashey, Nelli Bejanyan, Javier Bolaños Meade, Claudio G. Brunstein, Zachariah DeFilipp, Richard E. Champlin, Ephraim J. Fuchs, Mehdi Hamadani, Peiman Hematti, Christopher G. Kanakry, Joseph P. McGuirk, Ian K. McNiece, Stefan O. Ciurea, Marcelo C. Pasquini, Vanderson Rocha, Rizwan Romee, Sagar S. Patel, Sumithira Vasu, Edmund K. Waller, John R. Wingard, Mei-Jie Zhang, Mary Eapen
Publikováno v:
Blood Advances, Vol 3, Iss 19, Pp 2836-2844 (2019)
Abstract: In the absence of prospective studies that examine the effect of conditioning regimen intensity after T-cell–replete haploidentical transplant for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndr
Externí odkaz:
https://doaj.org/article/063425ac32074716842f8376472a505e
Autor:
Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K. Nooka, Salomon Manier, Natalie Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Michel Delforge, Jesus Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre-Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
Publikováno v:
New England Journal of Medicine. 388:1002-1014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3440321f2004e72b55d4ac3815f0b20e
https://doi.org/10.1056/nejmoa2213614
https://doi.org/10.1056/nejmoa2213614
Autor:
Melhem M. Solh, Gabriel Hinojosa, Justin Laporte, Scott R. Solomon, Lawrence E. Morris, Xu Zhang, H. Kent Holland, Asad Bashey
Publikováno v:
Advances in Hematology, Vol 2021 (2021)
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatly expanded donor availability and are increasingly utilized. Haplo were originally performed using truly nonmyeloablative conditioning and a bone marr
Externí odkaz:
https://doaj.org/article/88727edc4e9e4c2596f511b3eb65c6f4
Autor:
H. Kent Holland, Asad Bashey, Xu Zhang, Lawrence E. Morris, Chloe Farnham, Melhem Solh, Scott R. Solomon
Publikováno v:
Bone Marrow Transplantation. 58:168-174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25039d0aa09d1a8fa156f114f94435ce
https://doi.org/10.1038/s41409-022-01860-x
https://doi.org/10.1038/s41409-022-01860-x
Autor:
Alison, Sehgal, Daanish, Hoda, Peter A, Riedell, Nilanjan, Ghosh, Mehdi, Hamadani, Gerhard C, Hildebrandt, John E, Godwin, Patrick M, Reagan, Nina, Wagner-Johnston, James, Essell, Rajneesh, Nath, Scott R, Solomon, Rebecca, Champion, Edward, Licitra, Suzanne, Fanning, Neel, Gupta, Ronald, Dubowy, Aleco, D'Andrea, Lei, Wang, Ken, Ogasawara, Jerill, Thorpe, Leo I, Gordon
Publikováno v:
The Lancet Oncology. 23:1066-1077
Patients with relapsed or refractory large B-cell lymphoma after first-line treatment who are not intended for haematopoietic stem-cell transplantation (HSCT) have poor outcomes and limited treatment options. We assessed the antitumour activity and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7048a30eddf5ad18755f1aba03ca478
https://doi.org/10.1016/s1470-2045(22)00339-4
https://doi.org/10.1016/s1470-2045(22)00339-4
Autor:
Asad Bashey, Xu Zhang, Lawrence E. Morris, Henry Kent Holland, Lizamarie Bachier-Rodriguez, Scott R Solomon, Melhem M Solh
Publikováno v:
Blood Advances.
Few patients with non-favorable risk (NFR) acute leukemia and MDS (AL/MDS) have historically accessed allogeneic transplantation (HCT). We assessed whether this can be improved by the integration of HCT/leukemia care and use of haploidentical donors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36b4f324b532311798ca18ca452239b7
https://doi.org/10.1182/bloodadvances.2023009765
https://doi.org/10.1182/bloodadvances.2023009765
Autor:
Jeremy S. Abramson, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Manali Kamdar
Publikováno v:
Blood. 140:1581-1583
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01b8585158d9c3b6928f93a4cb8f9716
https://doi.org/10.1182/blood-2022-159702
https://doi.org/10.1182/blood-2022-159702
Autor:
Scott R. Solomon, Richard J. O'Reilly, Sergio Giralt, Raquel Palencia, Lori Muffly, Leyla Shune, Miguel-Angel Perales, Brent R. Logan, Mary M. Horowitz, Marcelo C. Pasquini, Nancy L. Geller, Richard J. Jones, Leo Luznik, Adam Mendizabal, Sumithira Vasu, Juan Wu, Johannes Schetelig, Steven M. Devine, Helen E. Heslop, Lynn O'Donnell, Eneida R. Nemecek, Mark R. Litzow, Robert J. Soiffer, Vincent T. Ho
Publikováno v:
J Clin Oncol
PURPOSE Calcineurin inhibitors (CNI) are standard components of graft-versus-host disease (GVHD) prophylaxis after hematopoietic cell transplantation (HCT). Prior data suggested that CNI-free approaches using donor T-cell depletion, either by ex vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1673d9f46ae452d239b8b6e18fd34e8d
https://doi.org/10.1200/jco.21.02293
https://doi.org/10.1200/jco.21.02293
Autor:
Jeremy S. Abramson, Patrick B. Johnston, Manali Kamdar, Sami Ibrahimi, Koji Izutsu, Jon Arnason, Bertram Glass, Pim Mutsaers, Matthew Lunning, Julia Braverman, Fei Fei Liu, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Shien Guo, Ling Shi, Scott R. Solomon
Publikováno v:
Blood advances, 6(23), 5969-5979. American Society of Hematology
Lisocabtagene maraleucel (liso-cel) has shown promising efficacy in clinical trials for patients with relapsed/refractory large B-cell lymphoma (LBCL). We present health-related quality of life (HRQOL) results from the TRANSFORM study, the first comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27781a50dd6e37b99197dd4e52835f64
https://pure.eur.nl/en/publications/4921a1b1-c6ca-4590-8679-4b1d4b8fabba
https://pure.eur.nl/en/publications/4921a1b1-c6ca-4590-8679-4b1d4b8fabba
